Research ArticleExperimental Studies

Use of an Extracellular Matrix Material as a Vaccine Carrier and Adjuvant

MARK A. SUCKOW, PAUL HALL, WILLIAM WOLTER, VALERIE SAILES and MICHAEL C. HILES
Anticancer Research September 2008, 28 (5A) 2529-2534;

Article Information

vol. 28 no. 5A 2529-2534
PMID 
19035274
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 3, 2008
  • Revision received July 28, 2008
  • Accepted August 11, 2008
  • Published online September 1, 2008.
Copyright & Usage 
Copyright© 2008 International Institute of Anticaner Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MARK A. SUCKOW1,
  2. PAUL HALL2,
  3. WILLIAM WOLTER1,
  4. VALERIE SAILES1 and
  5. MICHAEL C. HILES2
  1. 1Freimann Life Science Center, University of Notre Dame, Notre Dame, IN 46556
  2. 2Cook Biotech, Inc., West Lafayette, IN 47906, U.S.A.
  1. Correspondence to: Mark A. Suckow, Freimann Life Science Center, University of Notre Dame, Notre Dame, IN 46556, U.S.A. e-mail: Suckow.1{at}nd.edu

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Use of an Extracellular Matrix Material as a Vaccine Carrier and Adjuvant
MARK A. SUCKOW, PAUL HALL, WILLIAM WOLTER, VALERIE SAILES, MICHAEL C. HILES
Anticancer Research Sep 2008, 28 (5A) 2529-2534;
Twitter logo Facebook logo Mendeley logo

Jump to section